Genomic Alterations and Outcomes With Fixed-Duration Ibrutinib plus Venetoclax: Results From the Phase 3 GLOW Study in Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2023）
关键词
CLL, genomic aberration, gene mutation, ibrutinib, chemoimmunotherapy, chronic lymphocytic leukemia
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要